Intent to Sole Source_Quest Diagnostics_De-Identified Remnant Nasopharyngeal Specimens Tender

Procurement Summary

Country : USA

Summary : Intent to Sole Source_Quest Diagnostics_De-Identified Remnant Nasopharyngeal Specimens

Deadline : 03 May 2024

Other Information

Notice Type : Tender

TOT Ref.No.: 100368056

Document Ref. No. : 2024-86157

Financier : Self Financed

Purchaser Ownership : Public

Tender Value : Refer Document

Purchaser's Detail

Name :Login to see tender_details

Address : Login to see tender_details

Email : Login to see tender_details

Login to see details

Tender Details

Description

The Centers for Disease Control and Prevention (CDC), National Center for Immunization and Respiratory Diseases (NCIRD) intends to award a sole source firm fixed price purchase order to Quest Diagnostics for de-identified remnant nasopharyngeal specimens. Quest Diagnostics possesses residual nasopharyngeal specimens from diagnostic testing submitted from across the US public health jurisdiction, a random selection of which can be used as representative inputs for pertussis pathogen genomic surveillance. Additionally, their repository also includes negative specimens from suspected infection that can serve as valuable controls for laboratory assays. Comparable products are not available from other commercial sources in a timely manner and existing surveillance networks fail to recover sufficient numbers of representative specimens. Quest Diagnostics maintains a system for specimen collection and testing that broadly covers the general US population. The CDC will leverage an existing legal partnership to receive proprietary specimens from across the US. This contract action is for supplies or services for which the Government intends to solicit and negotiate with only one source under the authority of FAR 13.106-1(b) (SAP) and 10 U.S.C. 2304(c)(1). Interested persons may identify their interest and capability to respond to the requirement or submit proposals.

This notice of intent is not a request for competitive quotations; however, all quotations/responses received within fifteen (15) days of the issuance of this notice will be considered by the government. A determination by the government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. Any quotation/response should be emailed to contract specialist at email@cdc.gov by 4:00PM EST May 3, 20...
Active Contract Opportunity Notice ID 2024-86157 Related Notice Department/Ind. Agency HEALTH AND HUMAN SERVICES, DEPARTMENT OF Sub-tier CENTERS FOR DISEASE CONTROL AND PREVENTION
General Information
Contract Opportunity Type: Special Notice (Original)
All Dates/Times are: (UTC-04:00) EASTERN STANDARD TIME, NEW YORK, USA
Original Published Date: Apr 19, 2024 03:30 pm EDT
Original Response Date: May 03, 2024 04:00 pm EDT
Inactive Policy: 15 days after response date
Original Inactive Date: May 18, 2024
Initiative: None

Classification
Original Set Aside:
Product Service Code: 6550 - IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
NAICS Code: 325413 - In-Vitro Diagnostic Substance Manufacturing

Place of Performance: Atlanta, GA 30329 USA

Documents

 Tender Notice